Competition GAINS on McDonald’s and 4 HOT Stock Insights

Citrix Systems, Inc.’s (NASDAQ:CTXS) growth story is underappreciated and execution as well as growth will most likely push shares into a $95 price target, according to Morgan Stanley. The shares have an Overweight rating.

Watson Pharmaceuticals Inc. (NYSE:WPI): According to Morgan Stanley, competition from Concerta should not impact Watson Pharmaceuticals’ guidance for 2012 and it have favorable risk/reward. Shares are given an Overweight rating.

Don’t Miss: Here are the TOP Healthcare Sector POPS and DROPS.

Paychex Inc. (NASDAQ:PAYX) is still a solid defensive pick mostly following Q4 results in-line, says Baird. The firm adds that the company’s risk/reward is somewhat attractive at current levels due to defensive revenue characteristics as well as dividend yield. Shares have an Outperform rating.

ValueClick, Inc. (NASDAQ:VCLK) had a positive Q2 preannouncement which Needham thinks could reverse the shares’ recent downturn momentum. The firm maintains a Buy rating and a $22 price targets on the stock.

McDonald’s Corp. (NYSE:MCD): Due to a rise in U.S. competition as well as European concerns, Morgan Stanley thinks there may be near-term risk to McDonald’s Q2 results. Shares are given an Equal Weight rating.

Don’t Miss: Google Stakes Its Claim on Apple Territory.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.